resin
A resin is a solid or highly viscous liquid that can be converted into a polymer. Resins may be biological or synthetic in origin, but are typically harvested from plants. Resins are mixtures of organic compounds insoluble in water, predominantly terpenes. Technically, resins should not be confused with gums, which consist predominantly of water-soluble polysaccharides, although these two terms are often interchangeable in the less formal context. Common resins include pine oleoresins, amber, hashish, frankincense, myrrh and the animal-derived resin, shellac. Resins are used in varnishes, adhesives, food additives, incenses and perfumes. — Wikipedia
Clinical trial activity
4 trials · 5 clinical orgs · 0 marketing orgs
Earliest trial started Jan 1, 2008 (NCT01417832)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 2 Sponsor(trial)
Indications
Approved for
Mechanism of action
- UnclearUnclear
Unclear unclear
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02912741 | Phase 2 | Jan 1, 2017 | Cairo University |
| NCT03034837 | Phase 4 | Jan 1, 2016 | Zhengzhou University |
| NCT01851590 | Phase 4 | Oct 1, 2013 | Repolar Ltd., University of Helsinki |
| NCT01417832 | Phase 2/Phase 3 (Phase 3) | Jan 1, 2008 | Universidad El Bosque, Bogotá |
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cairo University | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Repolar Ltd. | For profit | 1 | 0 | 1 | 2013 |
| Universidad El Bosque, Bogotá | Academic/Hospital | 1 | 1 | 1 | 2008 |
| University of Helsinki | Academic/Hospital | 1 | 1 | 1 | 2013 |
| Zhengzhou University | Academic/Hospital | 1 | 1 | 1 | 2016 |